TGFβ1 polymorphisms and late clinical radiosensitivity in patients treated for gynecologic tumors
TGFβ1 polymorphisms and late clinical radiosensitivity in patients treated for gynecologic tumors
复制标题
DOI:
10.1016/j.ijrobp.2006.03.047
复制
发表时间:
2006-07-15
影响因子:
7
通讯作者:
Thierens, Hubert
中科院分区:
文献类型:
--
作者:
De Ruyck, Kim;Van Eijkeren, Marc;Thierens, Hubert
Purpose: To investigate the association between six transforming growth factor beta 1 gene (TGF beta 1) polymorphisms (-1.552delAGG, -800G > A, -509C > T, Leu10Pro, Arg25Pro, Thr263IIe) and the occurrence of late normal tissue reactions after gynecologic radiotherapy (RT).Methods and Materials: Seventy-eight women with cervical or endometrial cancer and 140 control individuals were included in the study. According to the Common Terminology Criteria for Adverse Events version 3.0 (CTCAEv3.0) scale, 25 patients showed late adverse RT reactions (CTC2+), of whom 11 had severe complications (CTC3+). Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), single base extension and genotyping assays were performed to examine the polymorphic sites in TGF beta 1.Results: Homozygous variant -1.552delAGG, -509TT, and 10Pro genotypes were associated with the risk of developing late severe RT reactions. Triple (variant) homozygous patients had a 3.6 times increased risk to develop severe RT reactions (p = 0.26). Neither the -800A allele, nor the 251'ro allele or the 2631[le allele were associated with clinical radiosensitivity. There was perfect linkage disequilibrium (LD) between the -1.552delAGG and the -509C>T polymorphisms, and tight LD between the -1.552/-509 and the Leu10Pro polymorphisms. Haplotype analysis revealed two major haplotypes but could not distinguish radiosensitive from nonradiosensitive patients.Conclusions: The present study shows that homozygous variant TGF beta 1 -1.552delAGG, -509TT, and 10Pro genotypes may be associated with severe clinical radiosensitivity after gynecologic RT. (c) 2006 Elsevier Inc.